Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Zanni

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
JACC. Advances|September 10, 2024
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIVChristopher deFilippi, Sara McCallum, Markella V Zanni, et al.
AIDS (London, England)|December 16, 2022
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIVPamela S Douglas, Sara McCallum, Michael T Lu, et al.
Open Forum Infectious Diseases|April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial CohortEmma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
The Lancet. HIV|May 1, 2026
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trialEsteban Martínez, Maya Watanabe, Risa Hoffman, et al.
The Journal of Infectious Diseases|July 10, 2020
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE TrialMarkella V Zanni, Judith S Currier, Amy Kantor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE CohortBorek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
AIDS (London, England)|July 25, 2022
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease riskKathleen V Fitch, Sara A McCallum, Kristine M Erlandson, et al.
The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
JACC. Advances|September 10, 2024
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIVChristopher deFilippi, Sara McCallum, Markella V Zanni, et al.
AIDS (London, England)|December 16, 2022
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIVPamela S Douglas, Sara McCallum, Michael T Lu, et al.
Open Forum Infectious Diseases|April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial CohortEmma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
The Lancet. HIV|May 1, 2026
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trialEsteban Martínez, Maya Watanabe, Risa Hoffman, et al.
The Journal of Infectious Diseases|July 10, 2020
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE TrialMarkella V Zanni, Judith S Currier, Amy Kantor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2023
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE CohortBorek Foldyna, Thomas Mayrhofer, Markella V Zanni, et al.
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
AIDS (London, England)|July 25, 2022
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease riskKathleen V Fitch, Sara A McCallum, Kristine M Erlandson, et al.
The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Pageof 15